New Hodgkin Lymphoma Drug Shows Promise

There were only 23 participants in the trial, but the results are encouraging. For 87% of patients the drug was effective at reducing tumors,and for 17% of the patients it was really effective… meaning the tumor was either completely gone or very nearly so.

This article was sourced from:

Andrew Pollack, New York Times


Josh Wolsky

Editor and Publisher of TheMinotVoice, Developer of the #ForMinot Network,  Co-Host of #GoodTalk Minot, Advocate and Friend of the Souris River, Former City Alderman, and clearly -- all things #MakeMinot. Go ahead, don't wait for permission!

Leave a Reply

Your email address will not be published. Required fields are marked *